. Studies find further lack of COVID benefit from hydroxychloroquine - IOPAC Press "Enter" to skip to content

Studies find further lack of COVID benefit from hydroxychloroquine

Chris Dall | News Reporter | CIDRAP NewsMay 15, 2020One of the studies is the first published randomized controlled trial on the drug for COVID-19.